Filing Details
- Accession Number:
- 0001140361-18-027202
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-04 17:57:07
- Reporting Period:
- 2018-06-01
- Accepted Time:
- 2018-06-04 17:57:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1196723 | David Pendarvis | Resmed Inc. 9001 Spectrum Center Blvd. San Diego CA 92123 | Chief Administrative Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Resmed Common Stock | Disposition | 2018-06-01 | 167 | $103.56 | 99,083 | No | 4 | F | Direct | |
Resmed Common Stock | Acquisiton | 2018-06-04 | 2,810 | $38.98 | 101,893 | No | 4 | M | Direct | |
Resmed Common Stock | Disposition | 2018-06-04 | 2,810 | $103.75 | 99,083 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Resmed Common Stock | ResMed Common Stock Options | Disposition | 2018-06-04 | 2,810 | $0.00 | 2,810 | $38.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,050 | 2013-11-11 | 2019-11-15 | No | 4 | M | Direct |
Footnotes
- Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on 06/01/2017.
- Includes 145 shares of ResMed stock purchased on April 30, 2018, through the ResMed Employee Stock Purchase Plan.
- The transaction was conducted under a Rule 10b5-1 plan.
- Represents date options first became exercisable. Options vest 1/3 per year.